Performances of a H. Pylori Stool PCR Test
NCT03566004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200
Last updated 2020-07-17
Summary
Performance of a non-invasive test for the detection of Helicobacter pylori and its resistance to clarithromycin in stool by Real-Time PCR Amplidiag H. pylori + ClariR (Mobidiag).
Conditions
- Helicobacter Pylori
Interventions
- DIAGNOSTIC_TEST
-
Stool specimen collection
The stool specimen collection was performed at the hospital or at home using a disposable device to be placed on the toilet seat and an E-nat Tube sent by postal to the lab.
Sponsors & Collaborators
-
Poitiers University Hospital
lead OTHER
Principal Investigators
-
Christophe BURUCOA · Poitiers University Hospital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-10
- Primary Completion
- 2020-06-09
- Completion
- 2020-06-09
Countries
- France
Study Locations
More Related Trials
-
Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection
NCT03361267 ·Status: UNKNOWN ·Phase: NA
-
Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection
NCT03555526 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Resistance
NCT05019586 ·Status: COMPLETED
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
The Study of the Antimicrobial Resistance of Helicobacter Pylori in Shandong Province
NCT04029415 ·Status: UNKNOWN
-
Tailored Therapy for Clarithromycin-Resistant H. Pylori
NCT03431688 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study
NCT06731023 ·Status: NOT_YET_RECRUITING
-
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
NCT01742429 ·Status: COMPLETED ·Phase: PHASE4
-
Helicobacter Pylori Eradication and Follow-up
NCT05061732 ·Status: RECRUITING ·Phase: PHASE4
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection
NCT05549115 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori Eradication Study
NCT03130452 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
NCT05742568 ·Status: COMPLETED ·Phase: PHASE4
-
Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
NCT02761005 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-center Study for Eradication of Refractory Helicobacter Pylori
NCT02741414 ·Status: UNKNOWN ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
NCT04332848 ·Status: RECRUITING ·Phase: PHASE4
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
NCT05431075 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
NCT01032655 ·Status: COMPLETED ·Phase: PHASE4
-
Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori
NCT01667575 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
NCT05100446 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP
NCT03148366 ·Status: COMPLETED ·Phase: PHASE3
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA